Enhanced Central Nervous System Transduction with Lentiviral Vectors Pseudotyped with RVG/HIV-1gp41 Chimeric Envelope Glycoproteins

Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: Brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug

(2011) Cátia Teixeira et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Enhanced pseudotyping efficiency of HIV-1 lentiviral vectors by a rabies/vesicular stomatitis virus chimeric envelope glycoprotein

(2011) D C J Carpentier et al.   GENE THERAPY

HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation

(2011) Mary Ann Checkley et al.   JOURNAL OF MOLECULAR BIOLOGY

A Lentiviral Strategy for Highly Efficient Retrograde Gene Transfer by Pseudotyping with Fusion Envelope Glycoprotein

(2010) Shigeki Kato et al.   HUMAN GENE THERAPY

Topology of the C-Terminal Tail of HIV-1 gp41: Differential Exposure of the Kennedy Epitope on Cell and Viral Membranes

(2010) Jonathan D. Steckbeck et al.   PLoS One

Pseudotyping lentiviral vectors with the wild-type measles virus glycoproteins improves titer and selectivity

(2009) S Funke et al.   GENE THERAPY

The Cytoplasmic Domain of Human Immunodeficiency Virus Type 1 Transmembrane Protein gp41 Harbors Lipid Raft Association Determinants

(2009) P. Yang et al.   JOURNAL OF VIROLOGY

The cell biology of rabies virus: using stealth to reach the brain

(2009) Matthias J. Schnell et al.   NATURE REVIEWS MICROBIOLOGY

Surface Exposure of the HIV-1 Env Cytoplasmic Tail LLP2 Domain during the Membrane Fusion Process

(2008) Lu Lu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Targeted Cell Entry of Lentiviral Vectors

(2008) Sabrina Funke et al.   MOLECULAR THERAPY